Neuramin (Thiamine Hydrochloride)

Thiamine Hydrochloride, the active ingredient in Neuramin, is a Vitamin B1 (thiamine) presented as a sterile solution for intramuscular and intravenous use. It is employed to treat thiamine deficiency‑related conditions such as beriberi and Wernicke’s encephalopathy, particularly in patients with chronic alcoholism or malnutrition.

GNH USA supplies Neuramin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neuramin is a vitamin B1 preparation used to correct thiamine deficiency and its neurological and cardiovascular complications. - Beriberi: restores thiamine stores, relieving peripheral neuropathy, edema and cardiac dysfunction. - Wernicke's encephalopathy: rapidly reverses confusion, ophthalmoplegia and ataxia in at‑risk patients. - Alcohol‑related malnutrition: prevents deficiency‑related neuro‑cognitive decline in chronic alcohol users. - General prophylaxis: maintains adequate thiamine levels during prolonged fasting or parenteral nutrition.

Thiamine Hydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Injection site pain or erythema. - Nausea or mild gastrointestinal upset. - Headache. - Dizziness. - Transient flushing or warmth. - Mild hypotension.

Serious or Rare Side Effects: - Anaphylactic reaction. - Severe hypotension or shock. - Acute allergic dermatitis. - Angioedema. - Respiratory distress. - Cardiovascular collapse.

Thiamine administration requires careful clinical assessment and monitoring. - Assess thiamine status: evaluate risk factors such as alcoholism, malnutrition or chronic illness. - Monitor for allergic reactions: observe for rash, itching or respiratory symptoms during and after injection. - Adjust in renal impairment: consider reduced clearance in severe kidney disease. - Use with caution in pregnancy or lactation: benefits should outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Thiamine may interact with other agents that affect its absorption, metabolism or clinical effect.

Major Interactions (Avoid): - High‑dose furosemide: can increase urinary thiamine loss, worsening deficiency. - Intravenous glucose without thiamine in at‑risk patients: may precipitate Wernicke’s encephalopathy. - Chronic alcohol consumption: impairs thiamine utilization, necessitating higher supplementation.

Moderate Interactions (Monitor Closely): - Anticonvulsants (phenytoin, phenobarbital): may accelerate thiamine metabolism. - Metformin: potential alteration of gastrointestinal absorption. - Certain chemotherapeutic agents: may increase thiamine requirements during treatment.